glp 1 dizzy spells GLP‑1 and dizziness: causes, red flags, and what helps GLP-1 drugs tied to elevated

However, current research faces several notable limitations: the tendency to focus on isolated aspects such as visitor experiences or aesthetic preferences rather than holistic public concerns

Bai, C., Biwersi, J., Verkman, A.S

Clinical studies addressing renal endpoints in patients with diabetic and no diabetic kidney diseases are warranted to provide information whether the promising preclinical findings can be translated into clinical benefit for patients with renal diseases

Jun 2019;1445(1):5-16

New oral GLP-1 drug helps maintain weight loss achieved with injectable drugs Patients who used the oral GLP-1 agonist orforglipron after losing weight with a subcutaneous GLP-1 medication were able to keep most of the weight off, a trial has found

doi:10.3389/fnut.2019.00093